Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Mancinelli CR, Scarpazza C, Cordioli C, De Rossi N, et al. Switching to ocrelizumab in RRMS patients at risk of PML previously treated with extended interval dosing of natalizumab. Mult Scler 2021;27:790-794.
PMID: 32749910


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016